ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

ERNA Eterna Therapeutics Inc

1.855
0.145 (8.48%)
May 03 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Eterna Therapeutics Inc ERNA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.145 8.48% 1.855 15:07:32
Open Price Low Price High Price Close Price Previous Close
1.80 1.72 2.00 1.855 1.71
more quote information »

Recent News

Date Time Source Heading
2/20/202407:30GLOBEEterna Therapeutics Announces the Appointment of Peter..
2/16/202416:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
2/16/202406:30EDGAR2Form 8-K - Current report
1/31/202406:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/24/202415:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
1/22/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
1/19/202415:16EDGAR2Form 8-K - Current report
1/19/202409:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/16/202415:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
1/12/202415:49EDGAR2Form S-3 - Registration statement under Securities Act of..
1/03/202416:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202416:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202416:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
1/03/202415:15GLOBEEterna Therapeutics Grants New President and CEO Sanjeev..
12/22/202311:05EDGAR2Form SC 13D/A - General statement of acquisition of..
12/20/202315:20EDGAR2Form 8-K - Current report
12/20/202315:15GLOBEEterna Therapeutics Names Sanjeev Luther as President and..
12/20/202314:24EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/20/202309:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/18/202320:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/14/202317:56GLOBEEterna Therapeutics Announces $9.2 Million Convertible Debt..
12/14/202315:30EDGAR2Form 8-K - Current report
11/16/202315:16EDGAR2Form 8-K - Current report
11/13/202316:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/13/202307:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/01/202307:34EDGAR2Form 8-K - Current report
11/01/202307:30GLOBEEterna Therapeutics Appoints James Bristol, Ph.D.,..
10/05/202315:30EDGAR2Form 8-K - Current report
9/26/202315:30EDGAR2Form 8-K/A - Current report: [Amend]
9/08/202305:07EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
9/07/202316:26EDGAR2Form SC 13D/A - General statement of acquisition of..
9/06/202307:00GLOBEEterna Therapeutics Announces Initiation of Development..
9/05/202307:30GLOBEEterna Therapeutics Appoints Biopharma Industry Veteran..
9/01/202316:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
8/31/202315:15EDGAR2Form 8-K - Current report
8/28/202315:57EDGAR2Form SC 13G - Statement of acquisition of beneficial..
8/25/202318:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/23/202306:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
8/14/202315:59EDGAR2Form S-3 - Registration statement under Securities Act of..
8/11/202315:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/10/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/10/202315:10EDGAR2Form 8-K - Current report
8/02/202316:25EDGAR2Form 8-K - Current report
7/26/202316:05EDGAR2Form SC 13D/A - General statement of acquisition of..
7/18/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/18/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/18/202307:05EDGAR2Form 8-K - Current report
7/18/202307:00GLOBEEterna Therapeutics Announces Completion of $8.7 Million of..
7/18/202305:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

Delayed Upgrade Clock